Drugs giants strike deal to advance cancer treatments (Update)
British pharmaceutical giant AstraZeneca and US peer Merck said Thursday they had agreed a multi-billion-dollar deal to jointly develop key cancer drugs.
Jul 27, 2017
British pharmaceutical giant AstraZeneca and US peer Merck said Thursday they had agreed a multi-billion-dollar deal to jointly develop key cancer drugs.
Jul 27, 2017
A cross government strategy, in place from 1997 to 2010, appears to have reduced health inequalities between the most deprived areas in England and the rest of the country, finds a study in The BMJ today.
Jul 27, 2017
The UK's proposed withdrawal from the European Atomic Energy Community (Euratom) would threaten the supply of essential medical isotopes (essential for some types of cancer treatment and medical imaging) putting patients ...
Jul 27, 2017